TOSK, INC.
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 1998-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.tosk.com
Phase 2a Study to Evaluate Suppression of 5-Fluorouracil -Induced Mucositis by TK112690
- First Posted Date
- 2023-01-03
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Tosk, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT05669521
- Locations
- ๐ฎ๐ณ
Saveetha Medical college Chennai, Chennai, Tamil Nadu, India
๐ฎ๐ณOm Sai Onco Surgery Multispecialty Hospital Center, Kolhapur, Maharashtra, India
๐ฎ๐ณJawaharlal Nehru Cancer Hospital and Research Centre, Bhopal, Madhya Pradesh, India
Phase 2a Study to Evaluate Suppression of Radiotherapy-induced Mucositis by TK112690
- First Posted Date
- 2022-12-20
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Tosk, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT05658016
- Locations
- ๐ฎ๐ณ
Saveetha Medical College and Hospita, Chennai, Tamil Nadu, India
๐ฎ๐ณApex Hospital, Varanasi, Uttar Pradesh, India
๐ฎ๐ณNetaji Subhash Chandra Bose Hospital, Kolkata, West Bengal, India
Phase 2a Study to Evaluate Suppression of Methotrexate-induced Mucositis by TK112690
- First Posted Date
- 2019-08-06
- Last Posted Date
- 2023-08-25
- Lead Sponsor
- Tosk, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT04046250
- Locations
- ๐ฎ๐ณ
Bangalore Cancer, Bangalore, Karnataka, India
๐ฎ๐ณKarnatak Cancer Therapy and Research Institute, Navanagar, Karnataka, India
๐ฎ๐ณNetaji Subhash Chandra Bose Cancer Hospital, Kolkata, West Bengal, India
ยฉ Copyright 2025. All Rights Reserved by MedPath